Concepedia

Kathryn A. Seely

KA

Statistics

Publications

17

Citations

1.4K

H-Index

15

Active since

2007

Affiliations

University of Arkansas for Medical Sciences(Current)

Arkansas Department of Health

Cayman Chemical (United States)

Arkansas Children's Hospital

Arkansas State University

Kathryn A. Seely is an author at University of Arkansas for Medical Sciences specializing in pharmacology, cannabinoid pharmacology, and medicine.

Publications per year

2007–2021

17

Publications

17

The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset

Jennifer L. Shoemaker, Kathryn A. Seely, Ronald L. Reed et al. · Journal of Neurochemistry · 2007 · 207 citations · Full text

, , +17

Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury

Joseph H. Holthoff, Zhen Wang, Kathryn A. Seely et al. · Kidney International · 2011 · 187 citations

, , +17

Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands

Krishna C. Chimalakonda, Kathryn A. Seely, Stacie M. Bratton et al. · Drug Metabolism and Disposition · 2012 · 186 citations · Full text

, , +17

Development of Oxidative Stress in the Peritubular Capillary Microenvironment Mediates Sepsis-Induced Renal Microcirculatory Failure and Acute Kidney Injury

Zhen Wang, Joseph H. Holthoff, Kathryn A. Seely et al. · American Journal Of Pathology · 2011 · 171 citations · Full text

, , +17

Forensic investigation of K2, Spice, and “bath salt” commercial preparations: A three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds

Kathryn A. Seely, Amy Patton, Cindy L. Moran et al. · Forensic Science International · 2013 · 107 citations

, , +17

1–5 of 17